By BRAD PERRIELLO Writer, Mass Device WARSAW — Medtronic‘s Covidien subsidiary wants the U.S. Supreme Court to hear its appeal in a patent infringement case against Johnson & Johnson‘s Ethicon Endo-Surgery unit over surgical shears. In December, 2014, the U.S. Court of Appeals for the Federal Circuit overturned a decision granting a $177 million award to Covidien in the U.S. …read more.

Medtronic (NYSE:MDT) announced in a press release today that it has bought out the remaining 70% share of NGC Medical S.p.A. in a deal valuing the Italian hospital management provider at $350 million. NGC Medical manages the cardiovascular suites, operating rooms and intensive care units at nearly 30 hospitals in Italy and is “rapidly expanding its service …read more.

The mega-merger of medtech titans Medtronic (NYSE:MDT) and Covidien (NYSE:COV) has some of Medtronic’s shareholders angry that they are being stuck with a tax penalty because of the structure of the $43 billion merger. MassDevice.com reports that some long-time backers of Medtronic have filed a lawsuit to block the merger and others appeared at the company’s …read more.

Medtronic (NYSE:MDT) could get a big hit if some Democrats in Congress are successful in their quest to pass a bill banning inverters from bidding for or winning federal contracts. Such companies have claimed as much as $1 billion in government dollars in the past 5 years. Hoping to curb what is being deemed a corporate exodus of …read more.

Medtronic Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, and Covidien plc (NYSE: COV), a global healthcare technology and medical supplies provider, today announced they have entered into a definitive agreement under which Medtronic has agreed to acquire Covidien in a cash-and-stock transaction valued at $93.22 per Covidien share, or a …read more.